M, K., A, A., & S, S. (2025). Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 39(1), 103. https://doi.org/10.1007/s40259-024-00696-9
Chicago Style (17th ed.) CitationM, Kacar, Al-Hakim A, and Savic S. "Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 39, no. 1 (2025): 103. https://doi.org/10.1007/s40259-024-00696-9.
MLA (9th ed.) CitationM, Kacar, et al. "Sequelae of B-Cell Depleting Therapy: An Immunologist's Perspective." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 39, no. 1, 2025, p. 103, https://doi.org/10.1007/s40259-024-00696-9.